Related Experiment Video
Updated: May 7, 2026

09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Single cell and spheroid collagen type I invasion assay
Olivier De Wever1, An Hendrix, Astrid De Boeck
1Department of Radiotherapy and Nuclear Medicine, Laboratory of Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
Methods in Molecular Biology (Clifton, N.J.)
|October 5, 2013
Summary
This study introduces a novel collagen invasion assay for cancer research. The method enables precise, real-time monitoring of tumor cell invasion through extracellular matrix, aiding in drug development.
Area of Science:
- Oncology
- Biotechnology
- Biophysics
Background:
- Tumor invasion is a critical process in cancer progression, driven by cancer cells interacting with the tumor microenvironment.
- Infiltration of dense collagen type I extracellular matrix is essential for cancer cell invasion.
- Current models often lack the resolution to capture dynamic cellular changes during invasion.
Purpose of the Study:
- To develop and validate a novel, membrane-free assay for studying cancer cell invasion through native collagen type I matrices.
- To enable real-time monitoring of cellular morphology and F-actin organization during invasion.
- To provide a reproducible and operator-independent platform for preclinical drug validation.
Main Methods:
- Utilized complementary single-cell and spheroid-based models in a membrane-free setup.
- Employed native collagen type I matrices for realistic extracellular matrix simulation.
- Integrated computerized quantification for data analysis.
- Allowed for real-time monitoring of cell morphology and F-actin organization using fluorescent probes.
Main Results:
- The developed assay preserves cell morphology, allowing detailed observation of invasion dynamics.
- Computerized quantification ensures high reproducibility and operator independence.
- The assay is versatile with flexible kinetic endpoints and compatibility with fluorescent probes.
- Demonstrated potential for preclinical validation of small-molecule inhibitors targeting cancer invasion.
Conclusions:
- The single-cell and spheroid invasion models offer a robust platform for studying cancer cell infiltration.
- This assay facilitates the assessment of anti-invasion therapies by providing reliable, quantitative data.
- The methodology supports efficient preclinical validation of therapeutic strategies targeting tumor invasion.

